Dow Down 0.56% Nasdaq Down 0.79%

Novogen Limited (NVGN)

-NasdaqCM
2.06 Down 0.04(1.90%) May 4, 3:58PM EDT
Prev Close:2.10
Open:2.05
Bid:N/A
Ask:2.53 x 1000
1y Target Est:5.00
Beta:0.564325
Next Earnings Date:N/A
Day's Range:2.05 - 2.09
52wk Range:1.79 - 7.66
Volume:25,522
Avg Vol (3m):41,937
Market Cap:34.86M
P/E (ttm):N/A
EPS (ttm):-0.57
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):27.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novogen Limited engages in the pharmaceutical research and development business in Australia. The company primarily has two drug technology platforms, which include superbenzopyran (SBPs) and anti-tropomyosin (ATMs). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback